Trials / Completed
CompletedNCT02399761
Newborn Screening for Aromatic L-amino Acid Decarboxylase Deficiency
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 154,795 (actual)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 3 Months
- Healthy volunteers
- Accepted
Summary
Parents of newborns will be invited to test if their newborns are affected with Aromatic L-amino Acid Decarboxylase (AADC) deficiency.
Detailed description
Parents of newborns will be invited to test if their newborns are affected with Aromatic L-amino Acid Decarboxylase (AADC) deficiency. The routine newborn screening dried blood spots sample will be used to test if 3-O-methyldopa (3-OMD) concentration elevates. If positive of screening test, further confirmation tests including physical examination and for mutation. Genetic counseling and treatment option will be provided, too.
Conditions
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2015-03-26
- Last updated
- 2017-04-28
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02399761. Inclusion in this directory is not an endorsement.